首页» 教育教学» 研究生导师

 

 鲍彦平    副研究员


 

   

 


       鲍彦平,医学博士,副研究员,博士生导师,北京大学中国药物依赖性研究所流行病室主任,中国毒理学会药物依赖性毒理学专业委员会委员,亚洲药物成瘾心理治疗专业委员会常务委员,多年来从事药物依赖及相关疾病预防干预与循证医学研究。主持了国家自然科学基金、十三五重点研发计划等多个科研项目。研究成果发表在Lancet, Lancet Psychiatry, Lancet Public Health, Molecular Psychiatry, Sleep medicine review等杂志上,共计发表科技论文100余篇。参与的多项研究荣获中华医学科技奖二等奖和教育部自然科学奖一等奖等省部级奖项,并获得北京大学医学部优秀青年学者奖及北京大学黄廷方/信和青年杰出学者奖。担任Frontiers in psychiatry杂志特邀编辑,《中国药物依赖性杂志》、《中国生化药物杂志》与《中国疼痛医学杂志》编委。

 

课题:

1.  重点研发计划, “抑郁障碍早期非药物干预技术研究”(2019YFA0706204), 时间:2019.12-2024.11,主持

2.  十三五国家重点研发计划,“我国合成毒品成瘾调查评估和复吸情况及影响因素研究”(2016YFC0800907-Z03),时间:2016.8-2019.7,主持

3.  国家食品药品监督管理局委托项目“舒芬太尼滥用风险调查与评价”,时间:2020.10-2021.9,共同主持

4.  国家食品药品监督管理局委托项目“哌甲酯滥用风险调查与评价”,时间:2020.10-2021.9,共同主持

5.  国家自然科学基金“苯丙胺类兴奋剂滥用人群中HIV感染状况及相关因素研究”(81001265),时间:2011.1-2013.12,主持

6.  十三五国家重点研发计划, “抑郁障碍早期非药物干预技术研究”(2019YFA0706204), 时间:2019.12-2024.11,主持

7.  十三五国家重点研发计划,“我国合成毒品成瘾调查评估和复吸情况及影响因素研究”(2016YFC0800907-Z03),时间:2016.8-2019.7,主持

8.  国家食品药品监督管理局委托项目“舒芬太尼滥用风险调查与评价”,时间:2020.10-2021.9,共同主持

9.   国家食品药品监督管理局委托项目“哌甲酯滥用风险调查与评价”,时间:2020.10-2021.9,共同主持

10. 国家自然科学基金“苯丙胺类兴奋剂滥用人群中HIV感染状况及相关因素研究”(81001265),时间:2011.1-2013.12,主持

 

发表文章:

1.    Wang Y#, Shi L#, Que J#, Lu Q, Liu L, Lu Z, Xu Y, Liu J, Sun Y, Meng S, Yuan K, Ran M, Lu L*Bao Y*, Shi J*.The impact of quarantine on mental health status among general population in China during the COVID-19 pandemic. Mol Psychiatry. 2021 Jan 22;1-10.

2.    Lu Q#, Zhang X#, Wang Y, Li J, Xu Y, Song X, Su S, Zhu X, Vitiello MV, Shi J*Bao YLu L*.Sleep disturbances during pregnancy and adverse maternal and fetal outcomes: A systematic review and meta-analysis. Sleep Med Rev. 2021 Jan 22;58:101436.

3.    Wang Y#, Liu M, Lu Q, Farrell M, Lappin JM, Shi J, Lu L*, Bao Y*. Global prevalence and burden of HIV-associated neurocognitive disorder: A meta-analysis. Neurology. 2020 Nov 10;95(19):e2610-e2621.

4.    Shi L#, Lu ZA#, Que JY, Huang XL, Liu L, Ran MS, Gong YM, Yuan K, Yan W, Sun YK, Shi J, Bao YP*, Lu L*. Prevalence of and Risk Factors Associated With Mental Health Symptoms Among the General Population in China During the Coronavirus Disease 2019 Pandemic.JAMA Netw Open. 2020 Jul 1;3(7) :e2014053.

5.    Wang YH#, Wang J#, Chen SH, Li JQ, Lu QD, Vitiello MV, Wang F, Tang XD, Shi J, Lu L*, Wu SL*, Bao YP*.Association of Longitudinal Patterns of Habitual Sleep Duration With Risk of Cardiovascular Events and All-Cause Mortality. JAMA Netw Open. 2020 May 1;3(5):e205246.

6.    Bao Y, Sun Y, Meng S, Shi J, Lu L. 2019-nCoV Epidemic: Address Mental Health Care to Empower Society. Lancet. 2020 Feb 22;395(10224):e37-e38.

7.    Liu JJ, Wang F, Liu H, Wei YB, Li H, Yue J, Que J, Degenhardt L, Lappin J, Lu LBao Y*, Wang J*.Ambient fine particulate matter is associated with increased emergency ambulance dispatches for psychiatric emergencies. Environ Res. 2019 Oct;177:108611.

8.    Bao Y, Meng S, Sun Y, Shi J, Lu L*. Healthy China Action plan empowers child and adolescent health and wellbeing. Lancet Public Health. 2019, 4(9):e448.

9.    Bao Y, Meng S, Shi J, Lu L*. Control of fentanyl-related substances in China. Lancet Psychiatry. 2019 Jul;6(7):e15.

10.   Ma J, Li XD, Wang TY, Li SX, Meng SQ, Blow FC, Ilgen M, Degenhardt L, Lappin J, Wu P, Shi J, Bao YP*, Lu L*. Relationship between the duration of methamphetamine use and psychotic symptoms: A two-year prospective cohort study. Drug Alcohol Depend. 2018 Apr 22;187:363-369.

11.   Ma J#, Bao YP#*, Wang RJ, Su MF, Liu MX, Li JQ, Degenhardt L, Farrell M, Blow FC, Ilgen M, Shi J*, Lu L*. Effects of medication-assisted treatment on mortality among opioids users: A systematic review and meta-analysis. Mol Psychiatry. 2018 Jun 22.

12.  Bao YP#*, Han Y#, Ma J, Wang RJ, Shi L, Wang TY, He J, Yue JL, Shi J, Tang XD, Lu L*. Cooccurrence and bidirectional prediction of sleep disturbances and depression in older adults: meta-analysis and systematic review. Neurosci Biobehav Rev. 2017 Feb 6;75:257-273.

13.  Wang TY#, Fan TT#, Bao YP*, Li XD, Liang CM, Wang RJ, Ma J, Han Y, Meng SQ, Wu P, Shi J, Lu L*. Pattern and related factors of cognitive impairment among chronic methamphetamine users. Am J Addict. 2017 Mar;26(2):145-151.

14.  Bao YP*, Liu ZM*, Li JH, Zhang RM, Hao W, Zhao M, Shi J, McGoogan JM, Lu L. Club drug use and associated high-risk sexual behaviour in six provinces in China. Addiction. 2015 Jan;110Suppl 1:11-9.